Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
04/2009
04/15/2009CN101406664A Chinese medicament preparation for tocolysis and preparation method thereof
04/15/2009CN101406659A Health-care plaster for breast
04/15/2009CN101406658A Medicine for treating primary menalgia
04/15/2009CN101406636A Chinese herbal medicine additive agent for increasing eggs
04/15/2009CN101406628A Pills for treating breast
04/15/2009CN101406623A Health-care wine for males
04/15/2009CN101406609A External-use medicament for treating breast inflammation of milk cattle
04/15/2009CN101406608A Medicine for treating cervical erosion
04/15/2009CN101406603A Chinese herbal compound for treating gynaecologic metrorrhagia disease
04/15/2009CN101406592A Medicament for treating infertility of milk cattle
04/15/2009CN101406558A Gynaecologic washing lotion for preventing and treating colpitis
04/15/2009CN101406552A Medicament for treating hysteromyoma and preparation method thereof
04/15/2009CN101406531A Chinese medicinal composition for treating dysmenorrhea and preparation method thereof
04/15/2009CN101406524A Vaginal lotion for cleaning, disinfecting and preventing diseases
04/15/2009CN101406515A Breast perfusate for treating mammitis of milk cattle and preparation thereof
04/15/2009CN101406513A Malaytea scurfpea fruit extract, pharmaceutical composition containing the same, and preparation method and application thereof
04/15/2009CN101406508A Pharmaceutical composition for repairing testicular senescense and damnification, and enhancing function of male
04/15/2009CN101406496A Prescription for treating prostatitis and other reproductive system diseases of male
04/15/2009CN101406477A Application of Breviscapine in preparing medicine
04/15/2009CN101406464A Treatment or prevention of urogenital atrophy and its symptoms in women
04/15/2009CN101406463A Method for preparing metronidazole, clotrimazole and chlorhexidime vaginal acetate effervescent tablet and quality control method
04/15/2009CN101406286A Gruel for promoting puerpera to lactate, and preparation method thereof
04/15/2009CN101406284A Pharmaceutical combination for preventing birth-defect and improving memory
04/15/2009CN100477990C Tanshinoue dropping pills and preparing method
04/15/2009CN100477988C Use of pogostemonis alkane type sesquiterpene compound as vegetative female sex normone
04/14/2009US7517989 Piperidine derivatives useful as modulators of chemokine receptor activity
04/14/2009US7517909 Using 3-amino-5-methyl-octanoic acid for therapy of psychiatric, pain and other disorders
04/14/2009US7517892 Ligands for monoamine receptors and transporters, and methods of use thereof
04/14/2009US7517658 Drug screening for human SNORF33 receptor agonist by contacting cells transfected with and expressing DNA encoding the human SNORF33 receptor, wherein cells prior to being transfected with the DNA do not express the human SNORF33 receptor; inflammation, infections, arthritis; autoimmune diseases
04/14/2009CA2445506C Use of sucralfate for the treatment of cervical erosion
04/14/2009CA2409841C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
04/14/2009CA2408934C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
04/14/2009CA2386190C Regulators of the hedgehog pathway, compositions and uses related thereto
04/14/2009CA2359440C Phenylphenanthridines with pde-iv inhibiting activity
04/14/2009CA2355341C The use of ara as a supplement for a lactating woman
04/14/2009CA2192941C Sterol derivatives used for regulation of meiosis
04/09/2009WO2009045505A2 Prohormones for increasing sexual performance
04/09/2009WO2009045337A1 Chemical sterilant for adult male dog population control, comprising a mineral gluconate and an amino acid
04/09/2009WO2009044788A1 Benzoxazinone derivative
04/09/2009WO2009043577A2 Contraceptive 19-nor progesterones
04/09/2009WO2009043106A1 Inorganic selenium and angiogenesis
04/09/2009WO2009019607A3 Beta adrenergic receptor ligand derivatives for modulating apoptosis
04/09/2009WO2009019433A3 Fertilisation protein
04/09/2009WO2008152093A3 Diaminopyrimidines as modulators of the ep2 receptor
04/09/2009WO2008054215A3 Use of 3-alpha-androstanediol, optionally in combination with a 5-ht1a agonist, in the treatment of sexual dysfunction
04/09/2009WO2008054213A3 Use of testosterone and a 5-ht1a agonist in the treatment of sexual dysfunction
04/09/2009US20090093547 Compositions and Methods for Treating Premature Ejaculation
04/09/2009US20090093546 Method and Pharmaceutical Compositions for Treatment of Anti-Estrogen Resistant Breast Cancer Using RXR Modulators
04/09/2009US20090093478 N-aroyl cyclic amines
04/09/2009US20090093448 19-nor-progesterone for contraception
04/09/2009US20090093433 SENSE mRNA THERAPY
04/09/2009US20090092696 Herbal combination omega oil aphrodisiac
04/09/2009US20090092689 Composition and method for supporting female sexual health
04/09/2009US20090092666 Vaccines with enhanced immune response and methods for their preparation
04/09/2009US20090092657 Amino acid combinant omega oil aphrodisiac
04/09/2009US20090092656 Method of treating atrophic vaginitis
04/09/2009CA2701406A1 Benzoxazinone derivative
04/08/2009EP2044943A1 Pharmaceutical compositions comprising esterified estrogens and methyltestosterone and method of using the same
04/08/2009EP2044942A1 Pharmaceutical preparation for continuous hormonal treatment over a period of 21-28 days comprising two ethinylestradio or estradio and drospirenone compositions
04/08/2009EP2044941A1 Multiple-phase formulation of drospirenone and estradiol as a contraceptive
04/08/2009EP2043648A1 Use of flibanserin for the treatment of sexual disorders in females
04/08/2009EP1706114A4 Chemical inhibitors of soluble adenylyl cyclase (sac)
04/08/2009EP1434600B1 Use of lh in controlled ovarian hyperstimulation
04/08/2009EP1415986B1 Spiro isobenzofuranes as neuropeptide y receptor antagonists
04/08/2009CN201216676Y Heat therapeutic underpants for women's menorrhalgia
04/08/2009CN101405010A 避孕组合物 Contraceptive composition
04/08/2009CN101402674A Functional peptide segment of epididymis protease inhibitors and uses thereof
04/08/2009CN101401937A Method of preparing coexpression PRRSV ORF5 and ORF6 double-gene nucleic acid vaccine
04/08/2009CN101401936A Method of preparing coexpression PRRSV ORF5 and PCV2 ORF2 bivalent nucleic acid vaccine
04/08/2009CN101401923A Oral medicine for headache and general edema in pregnancy period
04/08/2009CN101401919A Traditional Chinese medicine for preventing and controlling menorrhalgia
04/08/2009CN101401914A Medicine for treating hyperplasia of mammary glands
04/08/2009CN101401913A Traditional Chinese medicine composition for treating gland hyperplasia
04/08/2009CN101401903A Chinese medicinal composition for treating endometritis of cow
04/08/2009CN101401896A Active principle of sarsaparilla and extracting method thereof
04/08/2009CN101401884A Traditional Chinese medicine decoction for treating gland hyperplasia
04/08/2009CN101401864A External-use medicament for treating cervical erosion
04/08/2009CN101401862A External-use gelling agent for treating cervical erosion
04/08/2009CN100475843C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
04/08/2009CN100475842C Molecular structure of RHD negative genes locus
04/08/2009CN100475251C Medication for treating chronic appendages inflammation, and preparation method thereof
04/08/2009CN100475248C A medicine for treating metrorrhagia and preparation process thereof
04/08/2009CN100475241C Yankening medicine preparation and preparing method thereof
04/08/2009CN100475236C Medicine composition for treating women's pulvic infection, prepn process and use thereof
04/08/2009CN100475228C Ainsliaea fragrans champ extract and preparing method thereof
04/07/2009US7514564 Substituted amine derivatives and methods of use
04/07/2009US7514437 2-(2,4-difluorophenyl)-2-[(3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-isobutyl-2,5-dioxopiperazin-1-yl]-N,N-dimethylethanamide; to suppress uterine contractions; cyclization of leucine analogs
04/07/2009US7514422 To treat obesity, schizophrenia, anxiety, depression, alcoholism; using 3-benoazepine compounds like 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine (lorcaserin); serotonin 2c receptor agonists
04/07/2009US7514239 Nucleotide sequences coding polypeptide for use in the treatment of preferential glandular disorders
04/07/2009US7514221 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine-1 (MIC-1)
04/07/2009CA2390116C Triphenylalkene derivatives and their use as selective estrogen receptor modulators
04/07/2009CA2341991C Pyrroloindoles, pyridoindoles and azepinoindoles as 5-ht2c agonists
04/02/2009WO2009042127A2 Compositions and methods for rescuing fertility
04/02/2009WO2009010299A8 Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
04/02/2009WO2008116920A3 17beta-hydroxysteroid-dehydrogenase type 1 inhibitors for the treatment of hormone-dependent diseases
04/02/2009US20090088366 Nitrosated and nitrosylated prostaglandins, compositions and methods of use
04/02/2009US20090087474 Therapeutic use of growth factors,nsg29 and nsg31
04/01/2009EP2042598A1 5T4 tumour-associated antigen for use in tumour immunotherapy
04/01/2009EP2042184A1 Physiologically active polypeptide, polymer micelle having protein enclosed therein, and process for production of the polymer micelle
04/01/2009EP2042168A1 Inhalation device comprising phenethanolamine derivatives for treatment of respiratory diseases